Androgen receptor antagonist 13
Androgen receptor antagonist 13 (compound 8a) is an orally active Androgen receptor antagonist with an IC50 of 0.20 μM. Androgen receptor antagonist 13 can be used in the study of prostate cancer[1].
Product Specifications
CAS Number
2558183-91-6
UNSPSC
12352005
Target
Androgen Receptor
Related Pathways
Vitamin D Related/Nuclear Receptor
Field of Research
Cancer
Smiles
COC1=CC=C(C=C1)S(=O)(NC2=CC=C(C=C2)C3=CC=NN3)=O
Molecular Formula
C16H15N3O3S
Molecular Weight
329.37
References & Citations
[1]Bian C, et al. Design, synthesis and activity evaluation of benzene sulfonamide derivatives as novel androgen receptor antagonist. Eur J Med Chem. 2025 May 5;294:117712.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040813-100 1x 100 µL
CD74 (CLIP/813), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042858-100 1x 100 µL
CD3e (T-Cell Marker) (C3e/2858R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
